Of 60 depressed alcoholics who completed an open trial of imipramine,
27 (45%) responded with improvement in both mood and drinking behavior
, and eight (13%) responded after further dosage increases or treatmen
t with disulfiram. In a subsequent 6-month, randomized discontinuation
trial, four of 13 subjects (31%) relapsed during imipramine treatment
and seven of 10 (70%) relapsed while taking placebo. This suggests a
potential treatment approach for a risk subgroup of alcoholics.